Examkin

Soru

Zorluk: ZorPreventive Care and Screening

During a routine health maintenance visit, a 32-year-old female requests advice on her long-term cancer screening needs. She feels entirely well and has no acute concerns. Her past medical history is notable for classic Hodgkin lymphoma, which was diagnosed when she was a 21-year-old college student. At that time, her treatment consisted of 6 cycles of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) alongside involved-field radiation therapy to her neck and mediastinum. She achieved complete remission and has had no disease recurrence in the 11 years since.

Her family history is unremarkable for malignancies. She does not use tobacco, consumes alcohol in moderation, and exercises regularly. Vital signs are within normal limits. A thorough physical examination, including clinical breast and thyroid palpation, reveals no masses or adenopathy. Review of her records indicates a normal Pap smear and negative high-risk human papillomavirus testing performed 2 years ago.

Which of the following is the most appropriate next step in preventive care for this patient?

  1. A
    Biennial screening mammography starting at age 40
  2. B
    Routine thyroid ultrasonography
  3. Annual screening mammography and breast magnetic resonance imagingCevap
  4. D
    Low-dose chest computed tomography
  5. E
    BRCA1 and BRCA2 genetic testing

Cevap

The most appropriate step is annual screening mammography and breast magnetic resonance imaging.
The correct answer is annual screening mammography and breast magnetic resonance imaging (MRI). Patients who received ≥10\ge 10 Gy of thoracic radiation between the ages of 1010 and 3030 years (e.g., as part of mantle field radiation for Hodgkin lymphoma) have a significantly elevated lifetime risk of developing secondary breast cancer. This risk approaches that seen in patients with BRCA genetic mutations. Consequently, major oncology and radiology guidelines recommend high-risk screening for this population. This regimen consists of annual screening mammography and annual breast MRI beginning 88 years after the completion of radiation therapy, but not before age 2525. Since this patient was treated 1111 years ago at age 2121, she meets all criteria and should begin this intensive screening regimen immediately.

Adım Adım Çözüm

1
Identify the patient's major risk factor for secondary malignancies.
The patient received involved-field radiation therapy to the neck and mediastinum at age 21.
Prior medical treatments, especially radiation and certain chemotherapies during adolescence or young adulthood, significantly alter future cancer screening requirements.
2
Determine the appropriate breast cancer screening protocol based on this risk factor.
Guidelines recommend annual mammography and breast MRI starting 8 years after radiation or at age 25 (whichever is later) for women who received thoracic radiation between ages 10 and 30.
Thoracic radiation in this age window drastically increases the lifetime risk of breast cancer due to the direct exposure of developing breast tissue.
3
Evaluate the patient's current age and time since treatment to select the immediate next step.
The patient is 32 years old and it has been 11 years since her radiation therapy. Therefore, she is immediately due for annual mammography and breast MRI.
She meets both the age (≥25\ge 25 years) and time interval (≥8\ge 8 years) criteria to begin high-risk screening.

Anahtar Kavram

High-risk breast cancer screening after thoracic radiation
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru